Showing results (281-290 of 588) with videos related to

Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trialToni K Choueiri, David J Figueroa, André P Fay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2014
GRK3 is essential for metastatic cells and promotes prostate tumor progressionWenliang Li, Nanping Ai, Suming Wang, et al.
European Urology|December 17, 2018
Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate CancerAnis A Hamid, Kathryn P Gray, Grace Shaw, et al.
The Prostate|April 29, 2026
A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate CancerTravis A Gerke, Svitlana Tyekucheva, Konrad H Stopsack, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2021
Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate CancerClaire H Pernar, Giovanni Parmigiani, Edward L Giovannucci, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthaseDolores Di Vizio, Rosalyn M Adam, Jayoung Kim, et al.
BMC Cancer|July 27, 2021
Transcriptional landscape of PTEN loss in primary prostate cancerEddie Luidy Imada, Diego Fernando Sanchez, Wikum Dinalankara, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 12, 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell TherapyDavid J Einstein, Brian Halbert, Thomas Denize, et al.
Pageof 59